Kendall Law Group, led by former federal judge Joe Kendall, is investigating American Medical Systems Holdings Inc. (NASDAQ: AMMD) for shareholders in connection with the proposed acquisition by Endo Pharmaceuticals. The national securities firm’s investigation seeks to determine whether American Medical Systems and its Board breached their fiduciary duties by entering into the agreement without properly shopping for a deal that would provide better value for shareholders. If you are an American Medical Systems shareholder and would like additional information about your rights, contact the Kendall Law Group at 877-744-3728 or by email at email@example.com. On April 11, 2011, the companies announced the definitive merger agreement under which American Medical Systems would be acquired by Endo Pharmaceuticals, in a transaction valued at approximately $2.6 billion. Under the terms of the agreement, American Medical Systems stockholders will receive $30.00 in cash for each share of American Medical Systems/AMMD common stock held. The offer price represents a 34% premium to American Medical Systems’ Friday closing price. The firm’s investigation seeks to determine whether American Medical Systems and its Board undertook a fair process in negotiating the deal. Kendall Law Group was founded by a former federal judge, includes a former United States Attorney, prosecutors and securities lawyers who are experienced in complex securities litigation. The firm has been counsel in numerous merger and acquisition cases nationwide, including some of the largest transactions in the United States.